In this study we evaluated whether the interplay of both IFNL3 polymorphisms together with other non-genetic clinical factors such as the level of inflammatory activity, the ALT and GGT levels and metabolic factors such as the serum cholesterol concentration and the occurrence of steatosis is one reason for the outstanding predictive role of IFNL3 genetic variants. Here, IFNL3 is linked to steatosis.